Irogue Igbinosa: Rethinking Iron Deficiency in Pregnancy with Intravenous Therapy
Irogue Igbinosa, Maternal Fetal Medicine Physician at Stanford University School of Medicine, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Obstetrics and Gynecology:
“Publication Alert, excited to share that our recent trial: Intravenous Ferumoxytol Compared With Oral Ferrous Sulfate for Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial, was published recently.
Backstory: I’ve been working on since this trial since MFM (maternal fetal medicine fellow) fellowship.
Thankful for a team (Ijeoma Iwekaogwu, Elizabeth Sherwin, Stephanie Leonard, Deirdre Lyell and Caroline Berube) that helped from beginning to end.
Key Takeaway: Mild anemia in pregnancy should be treated and IV iron (ferumoxytol) should be considered as an option.”
Title: Intravenous Ferumoxytol Compared With Oral Ferrous Sulfate for Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial
Authors: Irogue I Igbinosa, Stephanie A Leonard, Ijeoma Iwekaogwu, Elizabeth B Sherwin, Caroline Berube, Deirdre J Lyell
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 21:19Ahmed Koriesh: Join Us for Future of Stroke Care 2026
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV
-
Jun 23, 2026, 19:20Simos Kokkovos: 1st Ever Mobile Stroke Unit in Greece is on its way to Metropolitan Hospital